Skip to content

Effect of aerobic exercise and consumption of curcumin on Premenstrual syndrome

Effect of aerobic exercise and consumption of curcumin on physiological parameters and edema in 18-35 years old women with premenstrual syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017010331745N1
Enrollment
44
Registered
2017-04-22
Start date
2016-06-04
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

premenstrual syndrome. Premenstrual tension syndrome

Interventions

Intervention 1: curcumin 100 mg oral capsules, twice a day (from a week before mense till 3 days after bleeding)for 3 months + aerobic exercise with 50-60 % maximum heart rate, 3 times a week, 1 hour
Treatment - Drugs
Placebo
Lifestyle
curcumin 100 mg oral capsules, twice a day (from a week before mense till 3 days after bleeding)for 3 months + aerobic exercise with 50-60 % maximum heart rate, 3 times a week, 1 hour each day, for 3
curcumin 100 mg oral capsules twice a day(from a week before mense till 3 days after bleeding) for 3 months
Corn starch 100 mg oral capsules twice a day(from a week before mense till 3 days after bleeding) for 3 months
Do aerobic exercise with 50-60 % maximum heart rate, 3 times a week, 1 hour daily, for 3 months

Sponsors

Vice Chancellor for research of Islamic Azad University Central Tehran Branch
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 18-35 year old; Having regular menstrual cycles ( 28-35 days); Suffering from moderate or severe PMS and at least have five physical symptoms based on Dickerson questionnaire; Do not Consumption effective drugs (chemical or herbal) on the premenstrual syndrome in the recent quarter. Exclusion criteria: physical and mental illnesses like diabetes, biliary or kidney disease, epilepsy, thyroid disease or other metabolic disorders; Consumption hormonal, anti convulsants and anti depression drugs; Smoking and drug abuse.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Physical Indicators of Premenstrual syndrome. Timepoint: before intervention and 3 months after intervention. Method of measurement: Dickerson standard questionnaire , blood Measurements.;Emotional Indicators of Premenstrual syndrome. Timepoint: before intervention and 3 months after intervention. Method of measurement: Dickerson standard questionnaire , blood Measurements.;Psychological Indicators of Premenstrual syndrome. Timepoint: before intervention and 3 months after intervention. Method of measurement: Dickerson standard questionnaire , blood Measurements.;Prostaglandin E2. Timepoint: before intervention and 3 months after intervention. Method of measurement: Dickerson standard questionnaire , blood Measurements.;Estrogen. Timepoint: before intervention and 3 months after intervention. Method of measurement: Dickerson standard questionnaire , blood Measurements.;Progesteron. Timepoint: before intervention and 3 months after intervention. Method of measurement: Dickerson standard questionnaire , blood Measurements.;Prolactin. Timepoint: before intervention and 3 months after intervention. Method of measurement: Dickerson standard questionnaire , blood Measurements.;Blood suger. Timepoint: before intervention and 3 months after intervention. Method of measurement: Dickerson standard questionnaire , blood Measurements.;Edema. Timepoint: before intervention and 3 months after intervention. Method of measurement: Dickerson standard questionnaire , blood Measurements.

Secondary

MeasureTime frame
Physical Indicators of Premenstrual syndrome. Timepoint: before intervention and 3 months after intervention. Method of measurement: Dickerson standard questionnaire , blood Measurements.;Emotional Indicators of Premenstrual syndrome. Timepoint: before intervention and 3 months after intervention. Method of measurement: Dickerson standard questionnaire , blood Measurements.;Prolactin. Timepoint: before intervention and 3 months after intervention. Method of measurement: Dickerson standard questionnaire , blood Measurements.;Progesteron. Timepoint: before intervention and 3 months after intervention. Method of measurement: Dickerson standard questionnaire , blood Measurements.;Psychological Indicators of Premenstrual syndrome. Timepoint: before intervention and 3 months after intervention. Method of measurement: Dickerson standard questionnaire , blood Measurements.;Blood suger. Timepoint: before intervention and 3 months after intervention. Method of measurement: Dickerson standard questionnaire , blood Measurements.;Esterogen. Timepoint: before intervention and 3 months after intervention. Method of measurement: Dickerson standard questionnaire , blood Measurements.;Prostaglandin E2. Timepoint: before intervention and 3 months after intervention. Method of measurement: Dickerson standard questionnaire , blood Measurements.;Edema. Timepoint: before intervention and 3 months after intervention. Method of measurement: Dickerson standard questionnaire , blood Measurements.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLadan Zoodfekr

Islamic Azad University

ladan_zoodfekr@yahoo.com, ladanzoodfekr@gmail.com+98 21 8807 4870

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026